financetom
Business
financetom
/
Business
/
What's Going On With Designer Brands Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Designer Brands Stock Today?
Sep 9, 2025 7:48 AM

Designer Brands Inc. ( DBI ) shares traded lower in the premarket session on Tuesday after reporting second-quarter adjusted earnings per share of 34 cents, beating the analyst consensus estimate of 23 cents.

Quarterly sales of $739.762 million (+4.2% year over year) beat the Street view of $737.845 million. Total comparable sales decreased by 5%.

Also Read: Robinhood May Hit $160 On 100% Revenue Growth By 2026: Bernstein

“Our second quarter results were highlighted by a 280-basis point sequential improvement in comparable sales from the first quarter, underscoring the impact of our targeted operational initiatives,” stated CEO Doug Howe.

Gross profit fell to $322.9 million from $339.5 million a year earlier. Gross margin slipped to 43.7% compared with 44.0% in the prior year.

Operating profit in the quarter under review decreased to $26.583 million, down from $28.589 million a year ago.

Howe noted that although consumer sentiment has improved somewhat, uncertainty persists due to tariff hikes and cautious discretionary spending, but stressed the company’s focus on disciplined execution and long-term sustainability.

“We anticipate our ongoing efforts to strengthen our brand, drive awareness through investments in marketing, and optimize our omni-channel model will continue to support our transformation,” the CEO said.

Cash and equivalents totaled $44.9 million at the end of the second quarter of 2025, compared to $38.8 million at the end of the same period last year.

The company ended the second quarter with inventories of $610.9 million compared to $642.8 million at the end of the same period last year.

Outlook

Designer Brands ( DBI ) said it will not reinstate full-year 2025 guidance.

The company cited macroeconomic uncertainty, mainly from global trade policies, as the reason.

Price Action: DBI shares are trading higher by 5.16% to $4.380 at last check on Tuesday.

Read next:

Ledger CTO Warns Of Ongoing NPM Supply Chain Attack, Advises Users To Halt Onchain Transactions

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Airbus reaffirms jet output goals amid strong demand
Airbus reaffirms jet output goals amid strong demand
Apr 10, 2024
AMSTERDAM, April 10 (Reuters) - Airbus voiced confidence in airplane output forecasts on Wednesday, telling shareholders it hoped to overcome lingering supply challenges at an Amsterdam meeting held against the backdrop of a deep corporate crisis at U.S. rival Boeing ( BA ). Shares in the France-based company have risen 16% since the start of the year, while Boeing (...
--Caterpillar Keeps Quarterly Dividend at $1.30 a Share, Payable May 20 to Shareholders of Record April 22
--Caterpillar Keeps Quarterly Dividend at $1.30 a Share, Payable May 20 to Shareholders of Record April 22
Apr 10, 2024
11:08 AM EDT, 04/10/2024 (MT Newswires) -- Price: 370.09, Change: -1.81, Percent Change: -0.49 ...
MarketAxess Needs Creativity to Retain US Credit Growth Trajectory as Innovation Track Record 'Spotty', BofA Securities Says
MarketAxess Needs Creativity to Retain US Credit Growth Trajectory as Innovation Track Record 'Spotty', BofA Securities Says
Apr 10, 2024
11:09 AM EDT, 04/10/2024 (MT Newswires) -- MarketAxess Holdings ( MKTX ) needs more creativity when it comes to protocols and data to retain its US credit growth trajectory, BofA Securities said in a note to clients Wednesday. The company has a spotty track record with innovation given its last big breakthrough was in 2012, the note said. In electronic...
Dr. Reddy's Launches Migraine Management Device Nerivio in Germany
Dr. Reddy's Launches Migraine Management Device Nerivio in Germany
Apr 10, 2024
11:06 AM EDT, 04/10/2024 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) said Wednesday that it has launched its drug-free migraine management wearable device Nerivio in Germany through its betapharm subsidiary. The company said it launched Nerivio in India in 2023 and will launch the device in South Africa later in April and in Spain and the UK in subsequent months....
Copyright 2023-2026 - www.financetom.com All Rights Reserved